The ongoing, high-profile case of Mylar’s EpiPen price hike is a perfect example of the kind of rent seeking that comes from overly strong patents.
The ongoing, high-profile case of Mylar’s EpiPen price hike is a perfect example of the kind of rent seeking that comes from overly strong patents.